Miguel Sanjuan
Corporate Officer/Principal bij PROVENTION BIO, INC.
Profiel
Miguel Sanjuan is currently the Senior Vice President-Research & Early Development at Provention Bio, Inc. Prior to this, he worked as the Vice President & Head-Translational Biology at Gossamer Bio, Inc. He completed his undergraduate degree at the University of Seville and his doctorate at Universidad Autónoma de Madrid.
Actieve functies van Miguel Sanjuan
| Bedrijven | Functie | Begin |
|---|---|---|
| PROVENTION BIO, INC. | Corporate Officer/Principal | - |
Eerdere bekende functies van Miguel Sanjuan
| Bedrijven | Functie | Einde |
|---|---|---|
| GOSSAMER BIO, INC. | Corporate Officer/Principal | 01-07-2021 |
Opleiding van Miguel Sanjuan
| University of Seville | Undergraduate Degree |
| Universidad Autónoma de Madrid | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| GOSSAMER BIO, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Provention Bio, Inc.
 Provention Bio, Inc. Pharmaceuticals: MajorHealth Technology Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D), PRV-015 for the treatment of gluten-free diet non-responding celiac disease, PRV-6527 for Crohn’s disease, PRV-3279 for the treatment of lupus, and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Red Bank, NJ. | Health Technology |
